Jork; Reinhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jork; Reinhard.The latest application filed is for "imidazotriazines for use as phosphodiesterase inhibitors".

Company Profile

0.8.6

Jork; Reinhard - Haan DE
Jork, Reinhard - Overath DE
Jork, Reinhard - Leverkusen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazotriazines for use as phosphodiesterase inhibitors Grant 6,936,609 - Erguden , et al. August 30, 2	2005-08-30
Imidazotriazines for use as phosphodiesterase inhibitors App 20040249148 - Erguden, Jens-Kerim ; et al.	2004-12-09
Arylsulphonamides and analogues Grant 6,727,279 - Mittendorf , et al. April 27, 2	2004-04-27
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases Grant 6,573,278 - Mittendorf , et al. June 3, 2	2003-06-03
Novel arylsulphonamides and analogues App 20030073727 - Mittendorf, Joachim ; et al.	2003-04-17
Use of chromans App 20020177616 - Fahrig, Thomas ; et al.	2002-11-28
Aryl sulphonamides and analogues Grant 6,469,054 - Mittendorf , et al. October 22, 2	2002-10-22
Arylsulfonamides and analogues App 20020072529 - Mittendorf, Joachim ; et al.	2002-06-13
Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration Grant 6,331,561 - Fahrig , et al. December 18, 2	2001-12-18
Use of known agonists of the central cannabinoid receptor CB1 App 20010034344 - Mittendorf, Joachim ; et al.	2001-10-25
Use of known agonists of the central cannabinoid receptor CB1 Grant 6,284,788 - Mittendorf , et al. September 4, 2	2001-09-04
Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration App 20010018530 - Fahrig, Thomas ; et al.	2001-08-30
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases Grant 6,262,112 - Mittendorf , et al. July 17, 2	2001-07-17
Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration Grant 6,235,774 - Fahrig , et al. May 22, 2	2001-05-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.